August 24, 2009
VANCOUVER, British ColumbiaA new, peer-reviewed study describing a toxicology study of Puratein® canola protein isolate was acceptance for publication in the journal of Food and Chemical Toxicology according to Burcon NutraScience Corporation. The animal study, titled A 13-week sub-chronic dietary toxicity study of a cruciferin-rich canola protein isolate in rats, evaluated the safety of the ingredient as a protein source at various dietary levels and confirmed that the companys canola protein isolate is safe for its intended use in food and beverage applications.
"With the publication of this study we are another step closer to having our canola protein isolates GRAS notified," said Johann F. Tergesen, Burcons president and C.O.O. Puratein canola protein is already GRAS self-affirmed, so it can already be sold commercially in the United States, but the company is seeking U.S. FDA GRAS notification to widen the market appeal.
Canola protein might find use in functional foods, as research shows the ingredient has positive impact on metabolic syndrome and cardiovascular health.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023